An emerging path for the autism community

Autism Plant Medicine

An innovative approach to nervous-system regulation for adults with autism — combining the wisdom of plant medicine with evidence-based neurofeedback and family-centered care.

Learn more → Watch the introduction
A New Path

Plant medicine is opening possibilities that did not exist for the autism community even a few years ago.

For many adults with autism, the accumulated weight of anxiety, sensory overwhelm, and trauma goes deeper than conventional therapies can reach. Medication manages symptoms. Behavioral approaches change patterns. But the underlying nervous-system dysregulation — often the real source of daily suffering — remains.

Psilocybin, the active compound in certain medicinal mushrooms, works differently. It engages the brain’s natural capacity for neuroplasticity — the ability to reorganize itself — creating a window in which patterns long locked in place can begin to shift. Growing research, shifting federal policy, and increasingly thoughtful clinical frameworks have converged to make careful plant medicine programs possible for the first time.

This is one of those programs. Built by families who know this landscape firsthand, grounded in what the science shows, and designed around the particular needs of the autism community.

Our Program

The Program

A nervous-system regulation program for adults with autism — and the people who love them.

Twelve weeks of gentle brain training. A medically supervised high-dose psilocybin retreat in a nature setting, preceded by a dress rehearsal the day before. Two weeks of structured integration following best practices from the psychedelic-assisted therapy field. Built by families, for families.

A brief overview of the program, the science behind it, and why this approach is different.

Why This Matters

A lifetime of invisible weight.

Many adults with autism live with persistent anxiety, sensory overload, trauma-related stress, and nervous-system instability — the accumulated cost of navigating a world that was not designed for them.

These experiences significantly reduce quality of life and constrain the expression of strengths, relationships, and independence that are otherwise available. Conventional approaches — cognitive behavioral therapy, medication, behavioral support — often fail to address the underlying nervous-system dysregulation that drives these patterns.

The program is not designed to change identity or “treat autism.” It is designed to reduce the burden of co-occurring dysregulation, anxiety, and trauma — conditions that are modifiable. The goal is nervous-system regulation, not neurotype change.

How It Works

Three phases, one arc.

Approximately seventeen weeks, designed to prepare the nervous system, transform it, and integrate the change.

01

NeurOptimal® Neurofeedback

Twelve weeks — approximately two sessions per week

A fully automated, non-invasive neurofeedback system with more than twenty-five years of development behind it. Sensors monitor brain activity two hundred and fifty-six times per second; when the system detects a shift in cortical patterns, it creates a brief interruption in the music the participant is listening to. The brain notices, recognizes something in its own activity triggered the pause, and begins to self-correct.

Sessions are passive: sit, listen, rest. Both the individual and their participating family members train concurrently — so that by the time the retreat arrives, everyone has learned what regulation feels like in their own body.

02

The Retreat Weekend

Two days, in a nature-based setting, under medical supervision

Day one is a dress rehearsal: participants spend the day in the exact room where the high-dose session will take place, under the effects of a lower but perceptual dose of psilocybin. The purpose is familiarity — the same people, the same space, the same sounds. By the end of Day One, nothing about the environment is unfamiliar.

Day two is the high-dose session itself, approximately six to eight hours, continuously supported by experienced clinical staff with a clear emergency response plan. Psilocybin acts through serotonin 5-HT2A pathways and has been shown to temporarily loosen entrenched neural patterns and support neuroplasticity.

03

Integration

Two weeks, structured and supported

Integration is where most of the durable benefit is realized. The psychedelic experience opens a window of enhanced neuroplasticity; integration is the structured practice of turning insights and shifts from that window into lasting change in daily life.

Participants work closely with the program team through facilitated conversations, journaling, mindfulness and somatic practices, and behavioral change planning — grounded in published best practices from the psychedelic-assisted therapy field.

The Difference

Family members go through the program two weeks before the person they support.

Parents, siblings, and caretakers complete their own neurofeedback and their own high-dose retreat first. By the time the individual with autism arrives at the retreat, the people supporting them already know, firsthand, exactly what they are walking into. This changes everything about the quality of support that is possible — during the experience, and in the integration that follows.

How We Hold This

Grounded in research, delivered with care.

I — Safety

Trauma-informed by design

Careful intake. Gradual pacing. Predictable structure. Ongoing consent, revisited at every phase transition. Close monitoring for overstimulation, shutdown, or dissociation. Predictability itself is a safety mechanism.

II — Measurement

Measured, not guessed at

Progress is tracked at three points using the Autism Treatment Evaluation Checklist — a validated instrument developed at the Autism Research Institute — alongside NeurOptimal® session data and video documentation.

III — Rigor

Built on published practice

Integration follows frameworks established by Bathje, Sloshower, Watts, and Luoma. Medical supervision at the retreat is continuous. Nothing is improvised where participant wellbeing is concerned.

The Moment

The landscape is shifting — quickly.

On April 18, 2026, a federal executive order accelerated access to psychedelic therapies, expanding pathways under the Right to Try Act and signaling a fundamental change in how these treatments will be integrated into care. Scientific, cultural, and now federal momentum has converged.

We are aware of the legal landscape and operate with appropriate care. At the same time, we believe the momentum behind this work is sufficient that this program does not need to wait for every regulatory detail to be settled before helping families who need help now.

Take the next step

If this feels right for your family, let’s talk.

There is no form to fill out, no application to navigate. Write a few lines about your situation — that is how every conversation begins.

To read the full program in depth: download the complete document (PDF)

The measure of success is not a published paper. It is whether the people we serve come out of this program with less anxiety, more regulation, better days, and stronger relationships — and whether we can deliver that to the next family, and the next.